Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
A Study of a Psilocybin Analog (CYB003) in Healthy Participants With and Without Major Depressive Disorder
Cybin IRL Limited
Effects of Psilocybin in Post-Treatment Lyme Disease
Johns Hopkins University
An Evaluation of Psilocybin's Effect on Cardiac Repolarization and the Effect of Food on Psilocybin's Pharmacokinetics
Usona Institute
The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
COMPASS Pathways
The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation
Sheppard Pratt Health System
Evaluation of Psilocybin (TRP-8802) in the Treatment of Binge Eating Disorder
TRYP Therapeutics
Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
Yvan Beaussant, MD, MSci
Frontline Clinician Psilocybin Study
University of Washington
Psilocybin for Treatment-Resistant Depression
Brain and Cognition Discovery Foundation
Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer
University of Utah
Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease
Joshua Woolley, MD, PhD
Repeat Dosing of Psilocybin in Migraine Headache
Yale University
Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression
Central Institute of Mental Health, Mannheim
Precision Functional Brain Mapping in Psilocybin
Washington University School of Medicine
Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study
Imperial College London
Pilot RECAP Study in Healthy Volunteers
University of Wisconsin, Madison
Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy
University of California, San Diego
Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder
New York State Psychiatric Institute
The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density
Section for Affective Disorders; Northern Stockholm Psychiatry
The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression
COMPASS Pathways
Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients
University of Zurich
Comparative Acute Effects of LSD, Psilocybin and Mescaline
University Hospital, Basel, Switzerland
A Study of Psilocybin for Major Depressive Disorder (MDD)
Usona Institute
Effects of Psilocybin in Anorexia Nervosa
Johns Hopkins University
Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy Subjects
University Hospital, Basel, Switzerland
Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin
University Hospital, Basel, Switzerland
Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of Concept
University of Zurich
The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression
COMPASS Pathways
Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms
Imperial College London
Psilocybin for Treatment of Obsessive Compulsive Disorder
University of Arizona
Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.
Yale University
Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors
Joshua Woolley
Psilocybin for the Treatment of Migraine Headache
Yale University
Effects of Psilocybin in Major Depressive Disorder
Johns Hopkins University
Persisting Effects of Psilocybin
Johns Hopkins University
Psilocybin for the Treatment of Cluster Headache
Yale University
Psilocybin-facilitated Treatment for Cocaine Use
University of Alabama at Birmingham
The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals
NYU Langone Health
Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion
Johns Hopkins University
UW Psilocybin Pharmacokinetics Study
University of Wisconsin, Madison
A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence
NYU Langone Health
Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
Johns Hopkins University
Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self
University of Zurich
Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
Johns Hopkins University
Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence
University of New Mexico
Psilocybin and Spiritual Practice
Johns Hopkins University
Psilocybin Cancer Anxiety Study
NYU Langone Health
Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study
Johns Hopkins University
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.